Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled 2×2 Factorial Study Evaluating Sucrose and Cold for the Treatment of Oral Pruritus During Allergy Procedures

NCT07917312 is registered in ClinicalTrials.gov with Philippe Bégin as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07917312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled 2×2 Factorial Study Evaluating Sucrose and Cold for the Treatment of Oral Pruritus During Allergy Procedures
Lead sponsor
Philippe Bégin
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
August 1, 2027
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, environmental allergies, food allergies, oral pruritus

Arms

As registered; 4 arms.

  • Sucrose only Active comparatorFood (sucrose)

    3.5 g granulated sugar

  • Cold only Active comparatorFood (popsicle)

    20 mL of ice in the form of popsicle

  • Sucrose and cold Active comparatorFood(Sucrose and cold)

    20 mL frozen sucrose solution

  • Water Placebo comparatorWater (Placebo)

    20 mL room-temperature water

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Area under the curve (AUC) of ICH NRS scores From baseline (pre-intervention) through 15 minutes post-intervention.

    Pruritus intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 (no itch) to 10 (worst imaginable itch). Higher scores indicate greater pruritus intensity and therefore a worse outcome.

Lead sponsor's other trials

Philippe Bégin, most recent start first.

Similar trials

Same condition (Environmental Illness) and phase, most recent start first.